Previous research on functional outcome in bipolar disorder (BD) has uncovered various factors that exacerbate psychosocial disability over the course of illness, including genetics, illness severity, stress, anxiety, and cognitive impairment. This paper presents an integrated view of these findings that accounts for the precipitous decline in psychosocial functioning after illness onset. The proposed model highlights a number of reciprocal pathways among previously studied factors that trap people in a powerful cycle of ailing forces. The paper discusses implications to patient care as well as the larger social changes required for shifting the functional trajectory of people with BD from psychosocial decline to growth. 1. Introduction Psychosocial functioning in bipolar disorder (BD) runs the full gamut of human potential. Whereas some people with BD accomplish historical landmarks in human achievement [1–3], others experience significant difficulties in managing tasks of daily living [4]. The remarkable functional variability in BD highlights an inherent prognostic complexity [5–7], which is not immediately evident in the diagnosis [8]. Many studies have illuminated various aspects of illness progression in BD [9–11], yet significant improvement to functional outcome may require further theoretical and clinical advancement [12]. The astounding functional differences among people with BD present one of the toughest challenges to this effort, as these emerge across the entire spectrum of human development [7, 13–16]. Early emotional abnormalities and poor premorbid functioning tend to occur in BD [17–19]; however, adequate psychosocial adjustment prior to the first manic episode is also common [20–22]. Furthermore, after illness onset, many people with BD regain psychosocial functioning [13, 23], yet others suffer inordinate functional decline, which progresses from a state of psychosocial adjustment to a state of disability [23, 24]. The latter group is of particular interest to clinical research. Understanding the nature of the sometimes dysfunctional trajectory of BD may help to diminish it, and thereby reduce suffering and cost. This paper examines the strongest predictors of functional outcome in BD, which have been separately summarized in multiple previous reviews. In this regard, the paper does not aim to provide a comprehensive review of studies linking each of the factors under discussion to psychosocial functioning in BD. Instead, it offers an integrated view on previously reviewed findings and discusses potential implications for prevention
References
[1]
N. Angier, “An old idea about genius wins new scientific support,” The New York Times, October 1993.
[2]
D. Blumer, “The illness of Vincent van Gogh,” American Journal of Psychiatry, vol. 159, no. 4, pp. 519–526, 2002.
[3]
J. H. MacCabe, M. P. Lambe, S. Cnattingius et al., “Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study,” British Journal of Psychiatry, vol. 196, no. 2, pp. 109–115, 2010.
[4]
R. Das Gupta and J. F. Guest, “Annual cost of bipolar disorder to UK society,” British Journal of Psychiatry, vol. 180, pp. 227–233, 2002.
[5]
J. F. Goldberg and M. Harrow, Bipolar Disorders: Clinical Course and Outcome, American Psychiatric Press, Washington, DC, USA, 1999.
[6]
A. Martinez-Aran, E. Vieta, C. Torrent et al., “Functional outcome in bipolar disorder: the role of clinical and cognitive factors,” Bipolar Disorders, vol. 9, no. 1-2, pp. 103–113, 2007.
[7]
J. Sanchez-Moreno, A. Martinez-Aran, R. Tabarés-Seisdedos, C. Torrent, E. Vieta, and J. L. Ayuso-Mateos, “Functioning and disability in bipolar disorder: an extensive review,” Psychotherapy and Psychosomatics, vol. 78, no. 5, pp. 285–297, 2009.
[8]
T. Treuer and M. Tohen, “Predicting the course and outcome of bipolar disorder: a review,” European Psychiatry, vol. 25, no. 6, pp. 328–333, 2010.
[9]
R. Bhattacharyya, M. K. Ghoshal, D. Sanyal, P. Guha, and S. Chakraborty, “Issues in estimating the course of rapid- cycling bipolar disorder,” American Journal of Psychiatry, vol. 166, no. 3, p. 370, 2009.
[10]
J. F. Goldberg, J. L. Garno, and M. Harrow, “Long-term remission and recovery in bipolar disorder: a review,” Current Psychiatry Reports, vol. 7, no. 6, pp. 456–461, 2005.
[11]
E. Vieta, “Long-term treatment of bipolar depression and other issues,” The Journal of Clinical Psychiatry, vol. 71, no. 3, article e07, 2010.
[12]
J. F. Goldberg, M. Harrow, and L. S. Grossman, “Course and outcome in bipolar affective disorder: a longitudinal follow- up study,” American Journal of Psychiatry, vol. 152, no. 3, pp. 379–384, 1995.
[13]
K. E. Burdick, J. F. Goldberg, and M. Harrow, “Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15 year follow-up,” Acta Psychiatrica Scandinavica, vol. 122, no. 6, pp. 499–506, 2010.
[14]
M. N. Pavuluri, L. S. Schenkel, S. Aryal et al., “Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients,” American Journal of Psychiatry, vol. 163, no. 2, pp. 286–293, 2006.
[15]
M. N. Pavuluri, A. West, S. K. Hill, K. Jindal, and J. A. Sweeney, “Neurocognitive function in pediatric bipolar disorder: 3-year follow-up shows cognitive development lagging behind healthy youths,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 48, no. 3, pp. 299–307, 2009.
[16]
J. Sanchez-Moreno, A. Martinez-Aran, H. F. Gadelrab et al., “The role and impact of contextual factors on functioning in patients with bipolar disorder,” Disability and Rehabilitation, vol. 32, no. 1, pp. S94–S104, 2010.
[17]
A. M. Passarotti, J. A. Sweeney, and M. N. Pavuluri, “Differential engagement of cognitive and affective neural systems in pediatric bipolar disorder and attention deficit hyperactivity disorder,” Journal of the International Neuropsychological Society, vol. 16, no. 1, pp. 106–117, 2010.
[18]
P. L. Rock, G. M. Goodwin, and C. J. Harmer, “The common adolescent bipolar phenotype shows positive biases in emotional processing,” Bipolar Disorders, vol. 12, no. 6, pp. 606–615, 2010.
[19]
M. Cannon, P. Jones, C. Gilvarry et al., “Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences,” American Journal of Psychiatry, vol. 154, no. 11, pp. 1544–1550, 1997.
[20]
A. Reichenberg, M. Weiser, J. Rabinowitz et al., “A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder,” American Journal of Psychiatry, vol. 159, no. 12, pp. 2027–2035, 2002.
[21]
M. Rietschel, A. Georgi, C. Schmael et al., “Premorbid adjustment: a phenotype highlighting a distinction rather than an overlap between schizophrenia and bipolar disorder,” Schizophrenia Research, vol. 110, no. 1–3, pp. 33–39, 2009.
[22]
S. Uzelac, J. Jaeger, S. Berns, and C. Gonzales, “Premorbid adjustment in bipolar disorder: comparison with schizophrenia,” Journal of Nervous and Mental Disease, vol. 194, no. 9, pp. 654–658, 2006.
[23]
L. L. Judd, P. J. Schettler, D. A. Solomon et al., “Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders,” Journal of Affective Disorders, vol. 108, no. 1-2, pp. 49–58, 2008.
[24]
L. L. Judd, H. S. Akiskal, P. J. Schettler et al., “Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study,” Archives of General Psychiatry, vol. 62, no. 12, pp. 1322–1330, 2005.
[25]
C. M. Bonnín, A. Martínez-Arán, C. Torrent et al., “Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study,” Journal of Affective Disorders, vol. 121, no. 1-2, pp. 156–160, 2010.
[26]
B. Arts, N. Jabben, L. Krabbendam, and J. Van Os, “Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives,” Psychological Medicine, vol. 38, no. 6, pp. 771–785, 2008.
[27]
L. J. Robinson, J. M. Thompson, P. Gallagher et al., “A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder,” Journal of Affective Disorders, vol. 93, no. 1–3, pp. 105–115, 2006.
[28]
I. J. Torres, V. G. Boudreau, and L. N. Yatham, “Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis,” Acta Psychiatrica Scandinavica, vol. 116, no. 434, pp. 17–26, 2007.
[29]
G. S. Malhi, B. Ivanovski, D. Hadzi-Pavlovic, P. B. Mitchell, E. Vieta, and P. Sachdev, “Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia,” Bipolar Disorders, vol. 9, no. 1-2, pp. 114–125, 2007.
[30]
A. Montoya, M. Tohen, E. Vieta et al., “Functioning and symptomatic outcomes in patients with bipolar i disorder in syndromal remission: a 1-year, prospective, observational cohort study,” Journal of Affective Disorders, vol. 127, no. 1–3, pp. 50–57, 2010.
[31]
M. Mur, M. J. Portella, A. Martinez-Aran, J. Pifarre, and E. Vieta, “Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients,” Psychopathology, vol. 42, no. 3, pp. 148–156, 2009.
[32]
A. P. Wingo, P. D. Harvey, and R. J. Baldessarini, “Neurocognitive impairment in bipolar disorder patients: functional implications,” Bipolar Disorders, vol. 11, no. 2, pp. 113–125, 2009.
[33]
F. Dickerson, A. Origoni, C. Stallings, S. Khushalani, D. Dickinson, and D. Medoff, “Occupational status and social adjustment six months after hospitalization early in the course of bipolar disorder: a prospective study,” Bipolar Disorders, vol. 12, no. 1, pp. 10–20, 2010.
[34]
J. Jaeger, S. Berns, S. Loftus, C. Gonzalez, and P. Czobor, “Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder,” Bipolar Disorders, vol. 9, no. 1-2, pp. 93–102, 2007.
[35]
D. J. Martino, E. Marengo, A. Igoa et al., “Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1year follow-up study,” Journal of Affective Disorders, vol. 116, no. 1-2, pp. 37–42, 2009.
[36]
M. Mur, M. J. Portella, A. Martínez-Arán, J. Pifarré, and E. Vieta, “Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients,” The Journal of Clinical Psychiatry, vol. 69, no. 5, pp. 712–719, 2008.
[37]
R. Tabarés-Seisdedos, V. Balanzá-Martínez, J. Sánchez-Moreno et al., “Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up,” Journal of Affective Disorders, vol. 109, no. 3, pp. 286–299, 2008.
[38]
H. H. Elshahawi, H. Essawi, M. A. Rabie, M. Mansour, Z. A. Beshry, and A. N. Mansour, “Cognitive functions among euthymic bipolar I patients after a single manic episode versus recurrent episodes,” Journal of Affective Disorders, vol. 130, no. 1-2, pp. 180–191, 2010.
[39]
C. López-Jaramillo, J. Lopera-Vásquez, A. Gallo et al., “Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence,” Bipolar Disorders, vol. 12, no. 5, pp. 557–567, 2010.
[40]
D. B. Yates, S. Dittmann, F. Kapczinski, and C. M. Trentini, “Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls,” Journal of Psychiatric Research, vol. 45, no. 4, pp. 495–504, 2010.
[41]
A. G. Gildengers, B. H. Mulsant, A. Begley et al., “The longitudinal course of cognition in older adults with bipolar disorder,” Bipolar Disorders, vol. 11, no. 7, pp. 744–752, 2009.
[42]
J. R. Sadek, D. A. White, K. I. Taylor et al., “Retrograde amnesia in dementia: comparison of HIV-associated dementia, Alzheimer's disease, and Huntington's disease,” Neuropsychology, vol. 18, no. 4, pp. 692–699, 2004.
[43]
M. Mur, M. J. Portella, A. Martínez-Arán, J. Pifarré, and E. Vieta, “Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit,” The Journal of Clinical Psychiatry, vol. 68, no. 7, pp. 1078–1086, 2007.
[44]
L. Clark, A. Sarna, and G. M. Goodwin, “Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression,” American Journal of Psychiatry, vol. 162, no. 10, pp. 1980–1982, 2005.
[45]
J. M. Thompson, J. M. Gray, J. R. Crawford, J. H. Hughes, A. H. Young, and I. N. Ferrier, “Differential deficit in executive control in euthymic bipolar disorder,” Journal of Abnormal Psychology, vol. 118, no. 1, pp. 146–160, 2009.
[46]
A. G. Gildengers, M. A. Butters, D. Chisholm et al., “Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder,” American Journal of Geriatric Psychiatry, vol. 15, no. 2, pp. 174–179, 2007.
[47]
S. Bell-McGinty, K. Podell, M. Franzen, A. D. Baird, and M. J. Williams, “Standard measures of executive function in predicting instrumental activities of daily living in older adults,” International Journal of Geriatric Psychiatry, vol. 17, no. 9, pp. 828–834, 2002.
[48]
M. Mitchell and L. S. Miller, “Prediction of functional status in older adults: the ecological validity of four Delis-Kaplan Executive Function System tests,” Journal of Clinical and Experimental Neuropsychology, vol. 30, no. 6, pp. 683–690, 2008.
[49]
D. R. Royall, R. Palmer, L. K. Chiodo, and M. J. Polk, “Declining executive control in normal aging predicts change in functional status: the Freedom House Study,” Journal of the American Geriatrics Society, vol. 52, no. 3, pp. 346–352, 2004.
[50]
J. Biederman, C. R. Petty, J. Wozniak et al., “Impact of executive function deficits in youth with bipolar I disorder: a controlled study,” Psychiatry Research, vol. 186, no. 1, pp. 58–64, 2010.
[51]
L. Altshuler, J. Tekell, K. Biswas et al., “Executive function and employment status among veterans with bipolar disorder,” Psychiatric Services, vol. 58, no. 11, pp. 1441–1447, 2007.
[52]
C. F. Yen, C. P. Cheng, C. F. Huang et al., “Relationship between psychosocial adjustment and executive function in patients with bipolar disorder and schizophrenia in remission: the mediating and moderating effects of insight,” Bipolar Disorders, vol. 11, no. 2, pp. 190–197, 2009.
[53]
S. Brissos, V. V. Dias, A. I. Carita, and A. Martinez-Arán, “Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates,” Psychiatry Research, vol. 160, no. 1, pp. 55–62, 2008.
[54]
S. Brissos, V. V. Dias, and F. Kapczinski, “Cognitive performance and quality of life in bipolar disorder,” Canadian Journal of Psychiatry, vol. 53, no. 8, pp. 517–524, 2008.
[55]
J. F. Goldberg and K. E. Burdick, Cognitive Dysfunction in Bipolar Disorder, American Psychiatric Publishing, Arlington, Va, USA, 2008.
[56]
A. M. Gilbert, T. M. Olino, P. Houck, A. Fagiolini, D. J. Kupfer, and E. Frank, “Self-reported cognitive problems predict employment trajectory in patients with bipolar I disorder,” Journal of Affective Disorders, vol. 124, no. 3, pp. 324–328, 2010.
[57]
P. E. Keck, S. L. McElroy, S. M. Strakowski et al., “12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode,” American Journal of Psychiatry, vol. 155, no. 5, pp. 646–652, 1998.
[58]
J. C. Hays, K. R. R. Krishnan, L. K. George, and D. G. Blazer, “Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates,” Depression and Anxiety, vol. 7, no. 2, pp. 76–82, 1998.
[59]
L. L. Judd, P. J. Schettler, H. S. Akiskal et al., “Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence,” Archives of General Psychiatry, vol. 65, no. 4, pp. 386–394, 2008.
[60]
L. B. Marangell, E. B. Dennehy, S. Miyahara et al., “The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD,” Journal of Affective Disorders, vol. 114, no. 1–3, pp. 58–67, 2009.
[61]
L. L. Hua, T. E. Wilens, M. Martelon, P. Wong, J. Wozniak, and J. Biederman, “Psychosocial functioning, familiality, and psychiatric comorbidity in bipolar youth with and without psychotic features,” The Journal of Clinical Psychiatry, vol. 72, no. 3, pp. 397–405, 2011.
[62]
F. Jaworski, C. Dubertret, J. Adès, and P. Gorwood, “Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia,” Psychiatry Research, vol. 185, no. 1-2, pp. 129–134, 2011.
[63]
T. V. Lagerberg, O. A. Andreassen, P. A. Ringen et al., “Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study,” BMC Psychiatry, vol. 10, article 9, 2010.
[64]
R. H. Perlis, E. B. Dennehy, D. J. Miklowitz et al., “Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study,” Bipolar Disorders, vol. 11, no. 4, pp. 391–400, 2009.
[65]
R. M. Post, G. S. Leverich, R. W. Kupka et al., “Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood,” The Journal of Clinical Psychiatry, vol. 71, no. 7, pp. 864–872, 2010.
[66]
E. Michalak, J. D. Livingston, R. Hole, et al., “‘It's something that I manage but it is not who I am’: reflections on internalized stigma in individuals with bipolar disorder,” Chronic Illness, vol. 7, no. 3, pp. 209–224, 2011.
[67]
P. Corrigan, “How stigma interferes with mental health care,” American Psychologist, vol. 59, no. 7, pp. 614–625, 2004.
[68]
E. E. Michalak, L. N. Yatham, S. Kolesar, and R. W. Lam, “Bipolar disorder and quality of life: a patient-centered perspective,” Quality of Life Research, vol. 15, no. 1, pp. 25–37, 2006.
[69]
D. A. Perlick, R. A. Rosenheck, J. F. Clarkin et al., “Adverse effects of perceived stigma on social adaptation of persons diagnosed with bipolar affective disorder,” Psychiatric Services, vol. 52, no. 12, pp. 1627–1632, 2001.
[70]
T. L. Scheid, “Stigma as a barrier to employment: mental disability and the Americans with Disabilities Act,” International Journal of Law and Psychiatry, vol. 28, no. 6, pp. 670–690, 2005.
[71]
G. H. Vázquez, F. Kapczinski, P. V. Magalhaes et al., “Stigma and functioning in patients with bipolar disorder,” Journal of Affective Disorders, vol. 130, no. 1-2, pp. 323–327, 2010.
[72]
D. C. Glahn, C. E. Bearden, C. L. Bowden, and J. C. Soares, “Reduced educational attainment in bipolar disorder,” Journal of Affective Disorders, vol. 92, no. 2-3, pp. 309–312, 2006.
[73]
N. Huxley and R. J. Baldessarini, “Disability and its treatment in bipolar disorder patients,” Bipolar Disorders, vol. 9, no. 1-2, pp. 183–196, 2007.
[74]
A. P. Wingo, R. J. Baldessarini, M. T. Compton, and P. D. Harvey, “Correlates of recovery of social functioning in types I and II bipolar disorder patients,” Psychiatry Research, vol. 177, no. 1-2, pp. 131–134, 2010.
[75]
L. N. Yatham, M. Kauer-SanT'Anna, D. J. Bond, R. W. Lam, and I. Torres, “Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the systematic treatment optimization program for early mania project,” Canadian Journal of Psychiatry, vol. 54, no. 2, pp. 105–112, 2009.
[76]
G. M. Goodwin, A. Martinez-Aran, D. C. Glahn, and E. Vieta, “Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report,” European Neuropsychopharmacology, vol. 18, no. 11, pp. 787–793, 2008.
[77]
A. Martínez-Arán, E. Vieta, F. Colom et al., “Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome,” Bipolar Disorders, vol. 6, no. 3, pp. 224–232, 2004.
[78]
A. Martínez-Arán, E. Vieta, M. Reinares et al., “Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder,” American Journal of Psychiatry, vol. 161, no. 2, pp. 262–270, 2004.
[79]
B. Levy, M. R. Stephansky, K. C. Dobie, B. A. Monzani, A. M. Medina, and R. D. Weiss, “The duration of inpatient admission predicts cognitive functioning at discharge in patients with bipolar disorder,” Comprehensive Psychiatry, vol. 50, no. 4, pp. 322–326, 2009.
[80]
F. Kapczinski, E. Vieta, A. C. Andreazza et al., “Allostatic load in bipolar disorder: implications for pathophysiology and treatment,” Neuroscience and Biobehavioral Reviews, vol. 32, no. 4, pp. 675–692, 2008.
[81]
B. S. McEwen and J. C. Wingfield, “The concept of allostasis in biology and biomedicine,” Hormones and Behavior, vol. 43, no. 1, pp. 2–15, 2003.
[82]
I. C. Chien, K. C. Chang, C. H. Lin, Y. J. Chou, and P. Chou, “Prevalence of diabetes in patients with bipolar disorder in Taiwan: a population-based national health insurance study,” General Hospital Psychiatry, vol. 32, no. 6, pp. 577–582, 2010.
[83]
A. Fagiolini, K. N. R. Chengappa, I. Soreca, and J. Chang, “Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden,” CNS Drugs, vol. 22, no. 8, pp. 655–669, 2008.
[84]
J. G. Fiedorowicz, N. M. Palagummi, V. L. Forman-Hoffman, D. D. Miller, and W. G. Haynes, “Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder,” Annals of Clinical Psychiatry, vol. 20, no. 3, pp. 131–137, 2008.
[85]
A. V. Steckert, S. S. Valvassori, M. Moretti, F. Dal-Pizzol, and J. Quevedo, “Role of oxidative stress in the pathophysiology of bipolar disorder,” Neurochemical Research, vol. 35, no. 9, pp. 1295–1301, 2010.
[86]
M. Berk, F. Kapczinski, A. C. Andreazza et al., “Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors,” Neuroscience and Biobehavioral Reviews, vol. 35, no. 3, pp. 804–817, 2011.
[87]
D. Arnone, J. Cavanagh, D. Gerber, S. M. Lawrie, K. P. Ebmeier, and A. M. McIntosh, “Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis,” British Journal of Psychiatry, vol. 195, no. 3, pp. 194–201, 2009.
[88]
S. M. Strakowski, C. M. Adler, S. K. Holland, N. P. Mills, M. P. DelBello, and J. C. Eliassen, “Abnormal fMRI brain activation in euthymic bipolar disorder patients during a counting stroop interference task,” American Journal of Psychiatry, vol. 162, no. 9, pp. 1697–1705, 2005.
[89]
I. Forcada, E. Papachristou, M. Mur et al., “The impact of general intellectual ability and white matter volume on the functional outcome of patients with Bipolar Disorder and their relatives,” Journal of Affective Disorders, vol. 130, no. 3, pp. 413–430, 2010.
[90]
N. M. Simon, M. W. Otto, S. R. Wisniewski et al., “Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD),” American Journal of Psychiatry, vol. 161, no. 12, pp. 2222–2229, 2004.
[91]
M. P. Freeman, S. A. Freeman, and S. L. McElroy, “The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues,” Journal of Affective Disorders, vol. 68, no. 1, pp. 1–23, 2002.
[92]
R. S. El-Mallakh and M. Hollifield, “Comorbid anxiety in bipolar disorder alters treatment and prognosis,” Psychiatric Quarterly, vol. 79, no. 2, pp. 139–150, 2008.
[93]
J. M. Azorin, A. Kaladjian, M. Adida et al., “Psychopathological correlates of lifetime anxiety comorbidity in bipolar i patients: findings from a French national cohort,” Psychopathology, vol. 42, no. 6, pp. 380–386, 2009.
[94]
C. Henry, D. V. Den Bulke, F. Bellivier, B. Etain, F. Rouillon, and M. Leboyer, “Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer,” The Journal of Clinical Psychiatry, vol. 64, no. 3, pp. 331–335, 2003.
[95]
K. R. Boylan, P. J. Bieling, M. Marriott, H. Begin, L. T. Young, and G. M. MacQueen, “Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder,” The Journal of Clinical Psychiatry, vol. 65, no. 8, pp. 1106–1113, 2004.
[96]
M. S. Bauer, L. Altshuler, D. R. Evans, T. Beresford, W. O. Williford, and R. Hauger, “Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder,” Journal of Affective Disorders, vol. 85, no. 3, pp. 301–315, 2005.
[97]
B. A. Gaudiano and I. W. Miller, “Anxiety disorder comobidity in Bipolar I Disorder: relationship to depression severity and treatment outcome,” Depression and Anxiety, vol. 21, no. 2, pp. 71–77, 2005.
[98]
C. F. Baldassano, “Illness course, comorbidity, gender, and suicidality in patients with bipolar disorder,” The Journal of Clinical Psychiatry, vol. 67, supplement 11, pp. 8–11, 2006.
[99]
M. Kauer-Sant'Anna, B. N. Frey, A. C. Andreazza et al., “Anxiety comorbidity and quality of life in bipolar disorder patients,” Canadian Journal of Psychiatry, vol. 52, no. 3, pp. 175–181, 2007.
[100]
S. Tse and M. Yeats, “What helps people with bipolar affective disorder succeed in employment: a grounded theory approach,” Work, vol. 19, no. 1, pp. 47–62, 2002.
[101]
F. T. Silva and J. R. Leite, “Physiological modifications and increase in state anxiety in volunteers submitted to the Stroop Color-Word Interference Test: a preliminary study,” Physiology and Behavior, vol. 70, no. 1-2, pp. 113–118, 2000.
[102]
A. C. Miu, R. M. Heilman, and D. Houser, “Anxiety impairs decision-making: psychophysiological evidence from an Iowa Gambling Task,” Biological Psychology, vol. 77, no. 3, pp. 353–358, 2008.
[103]
B. K. Lee, T. A. Glass, M. J. McAtee et al., “Associations of salivary cortisol with cognitive function in the Baltimore memory study,” Archives of General Psychiatry, vol. 64, no. 7, pp. 810–818, 2007.
[104]
C. Daban, E. Vieta, P. Mackin, and A. H. Young, “Hypothalamic-pituitary-adrenal axis and bipolar disorder,” Psychiatric Clinics of North America, vol. 28, no. 2, pp. 469–480, 2005.
[105]
J. Schmider, C. H. Lammers, U. Gotthardt, M. Dettling, F. Holsboer, and I. J. E. Heuser, “Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I,” Biological Psychiatry, vol. 38, no. 12, pp. 797–802, 1995.
[106]
J. K. Rybakowski and K. Twardowska, “The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness,” Journal of Psychiatric Research, vol. 33, no. 5, pp. 363–370, 1999.
[107]
N. Kobayashi, A. Yoshino, Y. Takahashi, and S. Nomura, “Autonomic arousal in cognitive conflict resolution,” Autonomic Neuroscience, vol. 132, no. 1-2, pp. 70–75, 2007.
[108]
E. A. Fertuck, S. Marsano-Jozefowicz, B. Stanley et al., “The impact of borderline personality disorder and anxiety on neuropsychological performance in major depression,” Journal of Personality Disorders, vol. 20, no. 1, pp. 55–70, 2006.
[109]
D. Fishbein, C. Hyde, D. Eldreth et al., “Cognitive performance and autonomic reactivity in abstinent drug abusers and nonusers,” Experimental and Clinical Psychopharmacology, vol. 13, no. 1, pp. 25–40, 2005.
[110]
J. K. Lee, S. M. Orsillo, L. Roemer, and L. B. Allen, “Distress and avoidance in generalized anxiety disorder: exploring the relationships with intolerance of uncertainty and worry,” Cognitive Behaviour Therapy, vol. 39, no. 2, pp. 126–136, 2010.
[111]
P. D. Harvey, A. P. Wingo, K. E. Burdick, and R. J. Baldessarini, “Cognition and disability in bipolar disorder: lessons from schizophrenia research,” Bipolar Disorders, vol. 12, no. 4, pp. 364–375, 2010.
[112]
F. R. Leifker, C. R. Bowie, and P. D. Harvey, “Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms,” Schizophrenia Research, vol. 115, no. 1, pp. 82–87, 2009.
[113]
C. Simonsen, K. Sundet, A. Vaskinn et al., “Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group,” Schizophrenia Bulletin, vol. 37, no. 1, pp. 73–83, 2011.
[114]
R. E. Bender and L. B. Alloy, “Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories,” Clinical Psychology Review, vol. 31, no. 3, pp. 383–398, 2011.
[115]
K. A. Dienes, C. Hammen, R. M. Henry, A. N. Cohen, and S. E. Daley, “The stress sensitization hypothesis: understanding the course of bipolar disorder,” Journal of Affective Disorders, vol. 95, no. 1–3, pp. 43–49, 2006.
[116]
R. T. Liu, “Early life stressors and genetic influences on the development of bipolar disorder: the roles of childhood abuse and brain-derived neurotrophic factor,” Child Abuse and Neglect, vol. 34, no. 7, pp. 516–522, 2010.
[117]
G. M. Hosang, R. Uher, R. Keers et al., “Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder,” Journal of Affective Disorders, vol. 125, no. 1–3, pp. 345–349, 2010.
[118]
R. E. Bender, L. B. Alloy, L. G. Sylvia, S. Uro?evic, and L. Y. Abramson, “Generation of life events in bipolar spectrum disorders: a re-examination and extension of the stress generation theory,” Journal of Clinical Psychology, vol. 66, no. 9, pp. 907–926, 2010.
[119]
R. M. Post, “Transduction of psychosocial stress into the neurobiology of recurrent affective disorder,” American Journal of Psychiatry, vol. 149, no. 8, pp. 999–1010, 1992.
[120]
S. Uro?evi?, L. Y. Abramson, E. Harmon-Jones, and L. B. Alloy, “Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence,” Clinical Psychology Review, vol. 28, no. 7, pp. 1188–1205, 2008.
[121]
S. Malkoff-Schwartz, E. Frank, B. P. Anderson et al., “Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes,” Psychological Medicine, vol. 30, no. 5, pp. 1005–1016, 2000.
[122]
M. H. J. Hillegers, H. Burger, M. Wals et al., “Impact of stressful life events, familial loading and their interaction on the onset of mood disorders: study in a high-risk cohort of adolescent offspring of parents with bipolar disorder,” British Journal of Psychiatry, vol. 185, pp. 97–101, 2004.
[123]
A. N. Cohen, C. Hammen, R. M. Henry, and S. E. Daley, “Effects of stress and social support on recurrence in bipolar disorder,” Journal of Affective Disorders, vol. 82, no. 1, pp. 143–147, 2004.
[124]
L. Yan-Meier, N. K. Eberhart, C. L. Hammen, M. Gitlin, K. Sokolski, and L. Altshuler, “Stressful life events predict delayed functional recovery following treatment for mania in bipolar disorder,” Psychiatry Research, vol. 186, no. 2-3, pp. 267–271, 2010.
[125]
G. M. Hosang, A. Korszun, L. Jones et al., “Adverse life event reporting and worst illness episodes in unipolar and bipolar affective disorders: measuring environmental risk for genetic research,” Psychological Medicine, vol. 40, no. 11, pp. 1829–1837, 2010.
[126]
L. Johnson, O. Lundstr?m, A. ?berg-Wistedt, and A. A. Mathé, “Social support in bipolar disorder: its relevance to remission and relapse,” Bipolar Disorders, vol. 5, no. 2, pp. 129–137, 2003.
[127]
S. L. Johnson, A. K. Cueller, C. Ruggero et al., “Life events as predictors of mania and depression in bipolar I disorder,” Journal of Abnormal Psychology, vol. 117, no. 2, pp. 268–277, 2008.
[128]
G. H. C. Shen, L. B. Alloy, L. Y. Abramson, and L. G. Sylvia, “Social rhythm regularity and the onset of affective episodes in bipolar spectrum individuals,” Bipolar Disorders, vol. 10, no. 4, pp. 520–529, 2008.
[129]
S. A. Hlastala and J. A. Varley, “Stress, social rhythms, and behavioral activation: psychosocial factors and the bipolar illness course,” Current Psychosis and Therapeutics Reports, vol. 2, no. 4, pp. 160–166, 2004.
[130]
N. Horesh and I. Iancu, “A comparison of life events in patients with unipolar disorder or bipolar disorder and controls,” Comprehensive Psychiatry, vol. 51, no. 2, pp. 157–164, 2010.
[131]
M. K. Holmes, K. Erickson, D. A. Luckenbaugh et al., “A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression,” Bipolar Disorders, vol. 10, no. 7, pp. 806–815, 2008.
[132]
U. Goswami, A. Sharma, A. Varma et al., “The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ,” Acta Psychiatrica Scandinavica, vol. 120, no. 6, pp. 456–463, 2009.
[133]
J. F. Goldberg and K. N. R. Chengappa, “Identifying and treating cognitive impairment in bipolar disorder,” Bipolar Disorders, vol. 11, no. 2, pp. 123–137, 2009.
[134]
C. Seale, R. Chaplin, P. Lelliott, and A. Quirk, “Antipsychotic medication, sedation and mental clouding: an observational study of psychiatric consultations,” Social Science and Medicine, vol. 65, no. 4, pp. 698–711, 2007.
[135]
V. Balanzá-Martínez, G. Selva, A. Martínez-Arán et al., “Neurocognition in bipolar disorders-A closer look at comorbidities and medications,” European Journal of Pharmacology, vol. 626, no. 1, pp. 87–96, 2010.
[136]
B. B. Dean, D. Gerner, and R. H. Gerner, “A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in bipolar disorder,” Current Medical Research and Opinion, vol. 20, no. 2, pp. 139–154, 2004.
[137]
M. L. Baldwin and S. C. Marcus, “Stigma, discrimination, and employment outcomes among persons with mental health disabilities,” in Work Accommodation and Retention in Mental Health, I. Z. Schultz and E. S. Rogers, Eds., pp. 53–69, Springer, New York, NY, USA, 2011.
[138]
K. E. Laxman, K. S. Lovibond, and M. K. Hassan, “Impact of bipolar disorder in employed populations,” American Journal of Managed Care, vol. 14, no. 11, pp. 757–764, 2008.
[139]
M. Garaigordobil and J. I. Pérez, “Self-concept, self-esteem and psychopathological symptoms in persons with intellectual disability,” Spanish Journal of Psychology, vol. 10, no. 1, pp. 141–150, 2007.
[140]
K. Marcussen, C. Ritter, and M. R. Munetz, “The effect of services and stigma on quality of life for persons with serious mental illnesses,” Psychiatric Services, vol. 61, no. 5, pp. 489–494, 2010.
[141]
S. A. Hlastala, J. S. Kotler, J. M. McClellan, and E. A. McCauley, “Interpersonal and social rhythm therapy for adolescents with bipolar disorder: treatment development and results from an open trial,” Depression and Anxiety, vol. 27, no. 5, pp. 457–464, 2010.
[142]
R. O'Shea, R. Poz, A. Michael, G. E. Berrios, J. J. Evans, and J. S. Rubinsztein, “Ecologically valid cognitive tests and everyday functioning in euthymic bipolar disorder patients,” Journal of Affective Disorders, vol. 125, no. 1–3, pp. 336–340, 2010.
[143]
S. Tse, “Practice guidelines: therapeutic interventions aimed at assisting people with bipolar affective disorder achieve their vocational goals,” Work, vol. 19, no. 2, pp. 167–179, 2002.
[144]
R. D. de Andrés, N. Aillon, M. C. Bardiot et al., “Impact of the life goals group therapy program for bipolar patients: an open study,” Journal of Affective Disorders, vol. 93, no. 1–3, pp. 253–257, 2006.
[145]
A. Martínez-Arán, C. Torrent, B. Solé, et al., “Functional remediation for bipolar disorder,” Clinical Practice and Epidemiology in Mental Health, vol. 7, article 112, 2011.
[146]
T. Deckersbach, A. A. Nierenberg, R. Kessler et al., “Cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms,” CNS Neuroscience and Therapeutics, vol. 16, no. 5, pp. 298–307, 2010.
[147]
D. J. Martino, A. Igoa, E. Marengo, M. Scápola, and S. A. Strejilevich, “Neurocognitive impairments and their relationship with psychosocial functioning in euthymic bipolar II disorder,” Journal of Nervous and Mental Disease, vol. 199, no. 7, pp. 459–464, 2011.
[148]
S. Frangou, S. Donaldson, M. Hadjulis, S. Landau, and L. H. Goldstein, “The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates,” Biological Psychiatry, vol. 58, no. 11, pp. 859–864, 2005.
[149]
R. H. Perlis, M. J. Ostacher, J. K. Patel et al., “Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD),” American Journal of Psychiatry, vol. 163, no. 2, pp. 217–224, 2006.
[150]
K. Grohman, W. Fals-Stewart, and K. Donnelly, “Improving treatment response of cognitively impaired veterans with neuropsychological rehabilitation,” Brain and Cognition, vol. 60, no. 2, pp. 203–204, 2006.
[151]
A. Martinez-Aran, J. Scott, F. Colom et al., “Treatment nonadherence and neurocognitive impairment in bipolar disorder,” The Journal of Clinical Psychiatry, vol. 70, no. 7, pp. 1017–1023, 2009.
[152]
A. Martínez-Arán, E. Vieta, F. Colom et al., “Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment?” Psychotherapy and Psychosomatics, vol. 74, no. 5, pp. 295–302, 2005.
[153]
O. Grynszpan, S. Perbal, A. Pelissolo et al., “Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study,” Psychological Medicine, vol. 41, no. 1, pp. 163–173, 2011.
[154]
D. I. Velligan, R. S. Kern, and J. M. Gold, “Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies,” Schizophrenia Bulletin, vol. 32, no. 3, pp. 474–485, 2006.
[155]
W. Fals-Stewart and W. K. K. Lam, “Computer-assisted cognitive rehabilitation for the treatment of patients with substance use disorders: a randomized clinical trial,” Experimental and Clinical Psychopharmacology, vol. 18, no. 1, pp. 87–98, 2010.
[156]
VA Connecticut Healthcare System. Cognitive Training to Enhance VA Work Outcomes. In: clinicalTrials.gov. Bethesda, Md, USA, National Library of Medicine (US), 2000, http://clinicaltrials.gov/show/NCT00829400.
[157]
North Shore Long Island Jewish Health System. Cognitive Enhancement in Bipolar Disorder. ClinicalTrials.gov. Bethesda, Md, USA, National Library of Medicine (US), 2000, http://clinicaltrials.gov/show/NCT00597896.
[158]
F. Colom, E. Vieta, J. Sánchez-Moreno et al., “Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis,” Journal of Affective Disorders, vol. 112, no. 1–3, pp. 30–35, 2009.
[159]
F. Colom, E. Vieta, J. Sánchez-Moreno et al., “Group psychoeducation for stabilised bipolar disorders: 5-Year outcome of a randomised clinical trial,” British Journal of Psychiatry, vol. 194, no. 3, pp. 260–265, 2009.
[160]
E. Brohan, D. Gauci, N. Sartorius, and G. Thornicroft, “Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: the GAMIAN-Europe study,” Journal of Affective Disorders, vol. 129, no. 1–3, pp. 56–63, 2010.
[161]
E. Brohan, M. Slade, S. Clement, and G. Thornicroft, “Experiences of mental illness stigma, prejudice and discrimination: a review of measures,” BMC Health Services Research, vol. 10, article 80, 2010.